2023
Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
Ellingson M, Sheikha H, Nyhan K, Oliveira C, Niccolai L. Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review. Human Vaccines & Immunotherapeutics 2023, 19: 2239085. PMID: 37529935, PMCID: PMC10399474, DOI: 10.1080/21645515.2023.2239085.Peer-Reviewed Original ResearchConceptsVaccine effectivenessSystematic reviewHuman Papillomavirus Vaccine EffectivenessVaccine-type HPV infectionYounger ageHigh vaccine effectivenessHuman papillomavirus vaccineVaccine effectiveness studiesYounger age groupsAdolescents ages 15Adolescents ages 9HPV infectionHPV vaccineVaccine initiationPapillomavirus vaccineTime vaccinationAnogenital wartsCervical abnormalitiesCervical cancerDisease outcomeAge groupsOlder ageEffectiveness studiesAge 15Age
2021
Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case–control study
Oliveira CR, Ortiz AM, Sheth SS, Shapiro ED, Niccolai LM. Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case–control study. BMJ Open 2021, 11: e043093. PMID: 33875441, PMCID: PMC8057558, DOI: 10.1136/bmjopen-2020-043093.Peer-Reviewed Case Reports and Technical NotesConceptsHigh-grade cervical lesionsPre-licensure clinical trialsHPV vaccineCase-control studyNumber of dosesClinical trialsFirst human papillomavirus (HPV) vaccineMultivariate conditional logistic regressionNormal Pap test resultsReal-world clinical settingHuman papillomavirus vaccinePap test resultsHPV types 16Time of immunisationReal-world effectivenessConditional logistic regressionInstitutional review boardDate of testingPapillomavirus vaccineCervical lesionsPotential confoundersVaccine programMedical recordsPersistent infectionType 16Inpatient Immunization With HPV Vaccine: A Qualitative Study With Postpartum Women
Avni-Singer L, Oliveira CR, Torres A, Shapiro ED, Niccolai LM, Sheth SS. Inpatient Immunization With HPV Vaccine: A Qualitative Study With Postpartum Women. Women's Health Issues 2021, 31: 384-391. PMID: 33715924, PMCID: PMC8260440, DOI: 10.1016/j.whi.2021.02.002.Peer-Reviewed Original ResearchConceptsHPV vaccinePostpartum womenPatient-centered approachHPV immunization programHuman papillomavirus vaccineRates of immunizationIterative thematic approachYoung adult femalesInpatient immunizationHospital dischargePapillomavirus vaccinePostpartum patientsMedian ageImmunization programsPatient's perspectiveProgram implementationVaccine hesitancyImmunizationVaccineWomenQualitative studyThematic approachPatientsHospitalAdult females
2020
Trends in Anogenital Wart Diagnoses in Connecticut, 2013-2017
Yakely AE, Niccolai LM, Oliveira CR. Trends in Anogenital Wart Diagnoses in Connecticut, 2013-2017. JAMA Network Open 2020, 3: e1920168. PMID: 32003814, PMCID: PMC7042856, DOI: 10.1001/jamanetworkopen.2019.20168.Peer-Reviewed Original ResearchConceptsAnogenital wart diagnosesHuman papillomavirus vaccineCross-sectional studyPapillomavirus vaccineAnogenital wartsModerate uptake
2017
Missed opportunities for HPV immunization among young adult women
Oliveira CR, Rock RM, Shapiro ED, Xu X, Lundsberg L, Zhang LB, Gariepy A, Illuzzi JL, Sheth SS. Missed opportunities for HPV immunization among young adult women. American Journal Of Obstetrics And Gynecology 2017, 218: 326.e1-326.e7. PMID: 29223597, PMCID: PMC5924702, DOI: 10.1016/j.ajog.2017.11.602.Peer-Reviewed Original ResearchConceptsHuman papillomavirus immunizationYoung adult womenGynecology clinicAdult womenMissed clinical opportunitiesVaccine-eligible visitsVaccine-eligible womenHuman papillomavirus vaccineMultivariable logistic regressionCross-sectional studyHospital-based obstetricsYears of ageYoung adult populationSignificant racial disparitiesUrban obstetricsPostpartum visitClinic visitsEligible womenPapillomavirus vaccinePatient characteristicsHPV immunizationHuman papillomavirusAdjusted oddsMedical recordsDifferent vaccines